News
CluePoints wins SCRIP Awards for Best Contract Research Organization (CRO): Specialist Providers
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) software for clinical trials, has won the Best Contract Research Organization (CRO): Specialist Providers category at Citeline’s 2023 SCRIP Awards.
The award, presented at The Dorchester...
News
Made Smarter national roll-out to turbo charge SME manufacturers in pharma
Made Smarter, a programme helping SME manufacturers in the pharmaceutical sector access technology and digital skills, is to be rolled out nationally.
The Government has committed to expanding the Made Smarter Adoption Programme to all nine English regions in 2025-26...
News
Clariness sets a new industry standard of >90% patient reachability with the launch of ClinLife Connect
Clariness announces that it has achieved a consistent patient reachability of over 90%, globally, since the deployment of AI-powered, ClinLife® Connect.
The newfound patient reachability is the result of integrating a new patient contact module into ClinLife®, which was developed using Silicon Valley founded state-of-the-art tech, and...
News
Odyssey Health Selects Syneos to Support Concussion Treatment Trial
Odyssey Health, Inc., a company focused on developing life-enhancing medical products, has selected Syneos Health, a biopharmaceutical services organization to support its Investigational New Drug (IND) Application. Odyssey Health is developing a pharmaceutical treatment for mild Traumatic Brain Injury...
Drug Research
Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics
Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development...
News
Chiesi, Haisco Partner on DPP1 Inhibitor for Respiratory Diseases
Chiesi Farmaceutici S.p.A, an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co. Ltd entered a licensing agreement to develop, manufacture, and commercialize outside China and adjacent territories (Hong Kong SAR, Macau SAR, and Taiwan District) HSK31858,...
News
Cryoport’s CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express
Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences announced the expansion of its global supply chain...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















